CB-839, panitumumab, and irinotecan in RAS wildtype (WT) metastatic colorectal cancer (mCRC): Phase I results.

Authors

Kristen Ciombor

Kristen Keon Ciombor

Vanderbilt University Medical Center, Nashville, TN

Kristen Keon Ciombor , Jennifer Whisenant , Dana Backlund Cardin , Laura Williams Goff , Satya Das , Michael Schulte , Allison Cohen , Robert J. Coffey , Gregory Dan Ayers , Rachel Krumsick , Susan Demo , Sam H. Whiting , H. Charles Manning , Jordan Berlin

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Translational Research

Clinical Trial Registration Number

NCT03263429

Citation

J Clin Oncol 37, 2019 (suppl 4; abstr 574)

DOI

10.1200/JCO.2019.37.4_suppl.574

Abstract #

574

Poster Bd #

G17

Abstract Disclosures